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to view.Direct Oral Anticoagulants: New Drugs and New Concepts 1333
Jerrold H. Levy, Alex C. Spyropoulos, Charles M. Samama, James DouketisDirect oral anticoagulants have a similar risk of clinically relevant bleeding compared with standard
anticoagulants and are associated with important reductions in intracranial bleeding in patients
with atrial ﬁbrillation. Certain patient (e.g., renal impairment, comedications) and drug (e.g.,
proportion of renal clearance) characteristics affect the risk of bleeding. Speciﬁc assays are
required to quantify plasma concentrations of direct oral anticoagulants, but an appropriate
traditional clotting test may at least exclude a clinically relevant anticoagulant effect. Bleeding
may be addressed with normal hemostatic support measures, but prohemostatic agents may be
considered for potentially life-threatening hemorrhage. New speciﬁc reversal agents for the direct
oral anticoagulants are currently undergoing clinical trials.CLINICAL RESEARCH
CORONARY A Randomized Comparison of Novel Biodegradable Polymer- and
Durable Polymer–Coated Cobalt-Chromium Sirolimus-Eluting Stents1352Yaling Han, Bo Xu, Quanmin Jing, Shuzheng Lu, Lixia Yang, Kai Xu, Yi Li, Jing Li,
Changdong Guan, Ajay J. Kirtane, Yuejin Yang, for the I-LOVE-IT 2 InvestigatorsThe I-LOVE-IT 2 (Evaluate Safety and Effectiveness of the Tivoli DES and the Firebird 2 DES for
Treatment of Coronary) trial compared safety and efﬁcacy of a novel biodegradable polymer
(BP)-coated cobalt-chromium (CoCr) sirolimus-eluting stent (SES) versus a durable polymer-coated
(DP)-SES on similar CoCr platforms, thereby isolating the effect of the polymer type. A total of
2,737 patients were randomly allocated to the BP-SES or DP-SES group in a 2:1 ratio. At 12 months,
the difference in the primary endpoint of target lesion failure (a composite of cardiac death,
myocardial infarction, and clinically indicated target lesion revascularization) between BP-SES
(6.3%) and DP-SES (6.1%) groups was 0.25% (95% conﬁdence interval: 1.67% to 2.17%, p for
noninferiority ¼ 0.0002), demonstrating noninferiority of BP-SES to DP-SES.
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DECEMBER 2014 VOLUME 7, NUMBER 12Scaffold and Edge Vascular Response Following Implantation of Everolimus-Eluting
Bioresorbable Vascular Scaffold: A 3-Year Serial Optical Coherence Tomography Study1361Yao-Jun Zhang, Javaid Iqbal, Shimpei Nakatani, Christos V. Bourantas,
Carlos M. Campos, Yuki Ishibashi, Yun-Kyeong Cho, Susan Veldhof, Jin Wang,
Yoshinobu Onuma, Hector M. Garcia-Garcia, Dariusz Dudek, Robert-Jan van Geuns,
Patrick W. Serruys, on behalf of the ABSORB Cohort B Study InvestigatorsThere is a lack of optical coherence tomography (OCT)–based in-scaffold response (SVR) and edge
vascular response (EVR) assessment after a bioresorbable scaffold implantation. In the ABSORB
Cohort B (ABSORB Clinical Investigation, Cohort B) study, 23 patients (23 lesions) in Cohort B1 and
17 patients (18 lesions) in Cohort B2 underwent truly serial OCT examinations. In the present
study, the authors demonstrated less luminal loss at the edges than luminal loss within the
scaffold. Thus, the luminal reduction of both edges is not a nosologic entity, but an EVR in
continuity with the SVR, extending from the in-scaffold margin to both edges.
SEE ADDITIONAL CONTENT ONLINEn EDITORIAL COMMENT
Shedding Light on Scaffold Vascular Response 1370
Bill (Vasileios) D. Gogas, Habib Samady
Outcomes in Patients With Cardiogenic Shock Following Percutaneous
Coronary Intervention in the Contemporary Era: An Analysis From the
BCIS Database (British Cardiovascular Intervention Society)1374Vijay Kunadian, Weiliang Qiu, Peter Ludman, Simon Redwood, Nick Curzen,
Rodney Stables, Julian Gunn, Anthony Gershlick, on behalf of the National Institute
for Cardiovascular Outcomes ResearchThis study sought to determine mortality rates among cardiogenic shock (CGS) patients
undergoing percutaneous coronary intervention (PCI) for acute coronary syndrome in the
contemporary treatment era and to determine predictors of mortality. In England and Wales,
6,489 patients underwent PCI for acute coronary syndrome in the setting of CGS. The mortality
rates at 30 days, 90 days, and 1 year were 37.3%, 40.0%, and 44.3%, respectively. In this large
U.K. cohort of patients undergoing PCI in the context of CGS, mortality remains high in spite of
the use of contemporary PCI strategies. The highest mortality occurs early, and this time period
may be a particular target of therapeutic intervention.
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DECEMBER 2014 VOLUME 7, NUMBER 12Pre-Angioplasty Instantaneous Wave-Free Ratio Pullback Provides
Virtual Intervention and Predicts Hemodynamic Outcome for Serial Lesions
and Diffuse Coronary Artery Disease1386Sukhjinder S. Nijjer, Sayan Sen, Ricardo Petraco, Javier Escaned,
Mauro Echavarria-Pinto, Christopher Broyd, Rasha Al-Lamee, Nicolas Foin,
Rodney A. Foale, Iqbal S. Malik, Ghada W. Mikhail, Amarjit S. Sethi,
Mahmud Al-Bustami, Rafﬁ R. Kaprielian, Masood A. Khan, Christopher S. Baker,
Michael F. Bellamy, Alun D. Hughes, Jamil Mayet, Darrel P. Francis, Carlo Di Mario,
Justin E.R. DaviesPressure wire assessment of stenoses can be hampered by the complex physiology of stenoses in
series or diffuse disease. Resting coronary physiology is potentially advantageous by allowing
stenosis-speciﬁc assessment and more powerful prediction of the post-stenting physiological
result. This study applies the instantaneous wave-free ratio to pressure wire pullback in diffuse
and tandem disease to develop a physiological map of coronary lesions. This map is used to
predict the post–percutaneous coronary intervention (PCI) result of stenting a given stenosis and
measure the physiological length of a lesion. Physiological mapping may assist in identifying and
planning PCI in complex disease.n EDITORIAL COMMENT
Pre-Angioplasty Instantaneous Wave-Free Ratio Pullback and Virtual
Revascularization: The Pressure Wire as a Crystal Ball1397Jan J. Piek, Tim P. van de Hoef
Incidence and Imaging Outcomes of Acute Scaffold Disruption and Late Structural
Discontinuity After Implantation of the Absorb Everolimus-Eluting Fully Bioresorbable
Vascular Scaffold: Optical Coherence Tomography Assessment in the ABSORB Cohort B
Trial (A Clinical Evaluation of the Bioabsorbable Everolimus Eluting Coronary Stent
System in the Treatment of Patients With De Novo Native Coronary Artery Lesions)1400Yoshinobu Onuma, Patrick W. Serruys, Takashi Muramatsu, Shimpei Nakatani,
Robert-Jan van Geuns, Bernard de Bruyne, Dariusz Dudek, Evald Christiansen,
Pieter C. Smits, Bernard Chevalier, Dougal McClean, Jacques Koolen,
Stephan Windecker, Robert Whitbourn, Ian Meredith, Hector M. Garcia-Garcia,
Susan Veldhof, Richard Rapoza, John A. OrmistonThe frequency and clinical impact of acute scaffold disruption and late strut discontinuity of the
Absorb scaffold was assessed on optical coherence tomography in the ABSORB (A Clinical
Evaluation of the Bioabsorbable Everolimus Eluting Coronary Stent System in the Treatment of
Patients With De Novo Native Coronary Artery Lesions) cohort B study post-procedure, at 6, 12,
24, and 36 months. Of 51 patients, acute scaffold disruption was observed in 2 patients. One
patient had a target lesion revascularization that was presumably related to the disruption. Late
discontinuities were observed in 21 patients. Acute scaffold disruption is a rare iatrogenic
phenomenon anecdotally associated with anginal symptoms, whereas late strut discontinuity could
be a bioresorption process without clinical implications.
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CONTENTS
PAGE A-23
DECEMBER 2014 VOLUME 7, NUMBER 12Outcomes After Percutaneous Coronary Intervention With Stents in Patients Treated
With Thoracic External Beam Radiation for Cancer1412Jackson J. Liang, Terence T. Sio, Joshua P. Slusser, Ryan J. Lennon, Robert C. Miller,
Gurpreet Sandhu, Abhiram PrasadThoracic external beam radiation therapy (EBRT) for cancer is associated with long-term cardiotoxic
sequelae, and the impact of EBRT in patients requiring coronary stents is unknown. The authors
analyzed outcomes after percutaneous coronary intervention (PCI) with stenting in patients
treated with EBRT before and after PCI. Compared with PCI-treated control patients without
EBRT, thoracic EBRT was not associated with increased rates of stent failure when used either
before or after PCI. Thus, their results suggest that PCI with stenting and EBRT may be safely
used in the same patient for treatment of coronary artery disease and cancer, respectively.
Relationship Between Inﬂammation and Beneﬁts of Early High-Dose Rosuvastatin
on Contrast-Induced Nephropathy in Patients With Acute Coronary Syndrome:
The Pathophysiological Link in the PRATO-ACS Study (Protective Effect of Rosuvastatin
and Antiplatelet Therapy on Contrast-Induced Nephropathy and Myocardial Damage
in Patients With Acute Coronary Syndrome Undergoing Coronary Intervention)1421Anna Toso, Mario Leoncini, Mauro Maioli, Francesco Tropeano, Emilio Di Vincenzo,
Simona Villani, Francesco BellandiIncreased inﬂammation evidenced by elevated C-reactive protein (CRP) levels is associated with
higher risk of cardiovascular and renal events. High-dose rosuvastatin administered on admission
has been shown to prevent contrast-induced acute kidney injury and improve short- and mid-term
clinical outcome in patients with acute coronary syndrome enrolled in the PRATO-ACS (Protective
Effect of Rosuvastatin and Antiplatelet Therapy on Contrast-Induced Acute Kidney Injury and
Myocardial Damage in ACS Patients) study. The present report shows that the higher the baseline
CRP levels, the higher the contrast-induced acute kidney injury and adverse event rates, and the
higher the beneﬁts of on-admission rosuvastatin administration. These ﬁndings represent a further
reason in favor of early use of high-dose statin therapy and assessment of CRP in acute coronary
syndrome patients.STRUCTURAL Results of the Combined U.S. Multicenter Pivotal Study and the Continuing Access Study
of the Nit-Occlud PDA Device for Percutaneous Closure of Patent Ductus Arteriosus1430John W. Moore, Jessica Greene, Salvadore Palomares, Alexander Javois, Carl Y. Owada,
John P. Cheatham, Mark H. Hoyer, Thomas K. Jones, Daniel S. Levi, for the Pivotal
and Continuing Access Studies of the Nit Occlud PDA InvestigatorsThe authors report the efﬁcacy and safety of the Nit-Occlud PDA device, a nitinol coil-type patent
ductus arteriosus occluder. Patients with small and moderate patent ductus arteriosus received
implantations and were followed for 12 months. Efﬁcacy and safety outcomes were compared to
objective performance criteria. A total of 347 patients had device implantations. After 12 months,
96.8% had echocardiographic closure and 98.1% had clinical closure. There were no deaths or
serious adverse events. The total adverse event rate was 4.7%. These outcomes compare
favorably with objective performance criteria.
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DECEMBER 2014 VOLUME 7, NUMBER 12Cardiac Catheterization in the Early Post-Operative Period After
Congenital Cardiac Surgery1437George T. Nicholson, Dennis W. Kim, Robert N. Vincent, Brian E. Kogon,
Bruce E. Miller, Christopher J. PetitThe reported experience with cardiac catheterization as a tool to assess post-operative concerns
is limited. The authors sought to demonstrate that early cardiac catheterization can be used
effectively with an acceptable risk in the early post-operative period. A total of 219
catheterizations (91 interventional procedures, 128 noninterventional catheterizations) were
performed on 193 patients. There was no difference in survival to hospital discharge between
those who underwent an interventional versus noninterventional catheterization (p ¼ 0.93).
One-year post-operative survival was comparable between those who underwent an interventional
(66%) versus diagnostic (71%) catheterization (p ¼ 0.58). Cardiac catheterization can be
performed safely in the immediate post-operative period after congenital heart surgery.PERIPHERAL Two-Year Life Expectancy in Patients With Critical Limb Ischemia 1444
Yoshimitsu Soga, Osamu Iida, Mitsuyoshi Takahaera, Keisuke Hirano, Kenji Suzuki,
Daizo Kawasaki, Yusuke Miyashita, Taketsugu TsuchiyaThe authors investigated patients with critical limb ischemia who do not have 2-year life expectancy
(2YLE). A 2YLE score based on the odds ratios of independent predictors (age, body mass index,
nonambulatory status, hemodialysis, cerebrovascular disease, left ventricular ejection fraction, and
tissue loss) was calculated. A 2YLE score of $8 points indicated a <50% probability of 2-year
survival.n EDITORIAL COMMENT
Critical Limb Ischemia and Intermediate-Term Survival 1450
Joshua A. Beckman, Mark A. CreagerIMAGES IN
INTERVENTIONRecanalized Thrombus Treated With Bioresorbable Vascular Scaffold:
Insights From Optical Coherence Tomography1453Omar Gómez-Monterrosas, Ander Regueiro, Alejandro Santos, Shuji Otsuki,
Giancarla Scalone, Diego Fernández-Rodríguez, Manel Sabaté
Left Ventricular Perforation During Ventriculogram Using an
Optitorque Tiger Catheter1456Jarrod D. Frizzell, Munif Alkouz, Mark W. SheldonCONTINUED ON PAGE A-25
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